Drug Type Small molecule drug |
Synonyms N-[[4-(2-dimethylaminoethoxy)phenyl]methyl]-3,4,5-trimethoxybenzamide, Trimethobenzamide, Trimethobenzamide hydrochloride (USP) + [1] |
Target |
Mechanism Histamine receptor antagonists |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (12 Jul 1974), |
Regulation- |
Molecular FormulaC21H29ClN2O5 |
InChIKeyWIIZEEPFHXAUND-UHFFFAOYSA-N |
CAS Registry554-92-7 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D02733 | Trimethobenzamide Hydrochloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Gastroenteritis | US | 12 Jul 1974 | |
Gastroenteritis | US | ENDO Medical, Inc.Startup | 12 Jul 1974 |
Gastroenteritis | US | 12 Jul 1974 | |
Gastroenteritis | US | 12 Jul 1974 | |
Postoperative Nausea and Vomiting | US | 12 Jul 1974 | |
Postoperative Nausea and Vomiting | US | 12 Jul 1974 | |
Postoperative Nausea and Vomiting | US | 12 Jul 1974 | |
Postoperative Nausea and Vomiting | US | ENDO Medical, Inc.Startup | 12 Jul 1974 |
Phase 4 | 127 | ocaxrsiyja(irdwnkmket) = lxjjpidtau ctnbxtcuqa (pfoiheorpy, caoibesflu - tevwljdgnh) View more | - | 07 Sep 2015 | |||
Phase 4 | 117 | xlntzyvgmu(arrrawdjtv) = ppqntmfrge nwegnocmrn (vmdkwutjjr, pcxwgbyjye - rfmubniyqi) View more | - | 20 May 2013 |